Results per Page:
20 years since Fred Hutch president helped make EGFR discovery, woman with stage 4 lung cancer is thriving
Dr. Tom Lynch described how targeted therapies could dramatically improve patient outcomes
Mapping novel “beacons” for targeted therapy in prostate cancer
From the Haffner lab, Human Biology and Clinical Research Divisions
Mutant’s partner in crime could be target for future cancer therapy
Fred Hutch scientists discover a new player — and possible drug target — in a critical biological process that’s skewed in tumors with certain mutations
Bioengineer Aaron Ring receives Anderson Family Endowed Chair for Immunotherapy
Chair will support innovative immunotherapeutic approaches to cancer drug target discovery
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Remembering leukemia researcher Dr. Steve Collins
Among 'a lot of brilliant guys,' the leukemia clinician-researcher stood out for his science — and much more
Good News: Dr. Oliver Press wins mentorship award; Seattle magazine names Dr. Larry Corey to Seattle's 'Hall of Fame'
Celebrating faculty and staff achievements
‘Future of oncology’: New playbook for precision medicine
Fred Hutch researcher helps lay crucial groundwork for precision medicine, improved patient care